World-first LAF assay accelerates cancer research A groundbreaking technique developed at the Australian Institute for Bioengineering and Nanotechnology (AIBN) is redefining how scientists study the bloodstream’s tiniest particles. Lipoprotein Association Fluorometry (LAF) is a world-first assay that can rapidly measure interactions between extracellular vesicles (EVs) and lipoproteins—crucial steps in understanding how cancers develop, spread, and…